WDB coco Co (TSE:7079) Total Current Assets : 円3,538 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. WDB coco Co's total current assets for the quarter that ended in Dec. 2023 was 円3,538 Mil.

WDB coco Co Total Current Assets Historical Data

The historical data trend for WDB coco Co's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co Total Current Assets Chart

WDB coco Co Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Current Assets

Get a 7-Day Free Trial

956.23

1,573.46

1,921.39

2,758.82

3,047.78

WDB coco Co Quarterly Data
	Mar18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Current Assets	Get a 7-Day Free Trial															3,013.71	3,047.78	3,094.55	3,344.79	3,538.43

WDB coco Co Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

WDB coco Co's Total Current Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2001.899	+	1023.953	+	1.645	+	20.285
	=	3,048

WDB coco Co's Total Current Assets for the quarter that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	2264.232	+	1245.779	+	2.462	+	25.954
	=	3,538

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

WDB coco Co (TSE:7079) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

WDB coco Co's Liquidation Value for the quarter that ended in Dec. 2023 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2264.232	-	855.732	+	0.75 * 1245.779	+	0.5 * 2.462
=	2,344

WDB coco Co Total Current Assets Related Terms

Thank you for viewing the detailed overview of WDB coco Co's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

WDB coco Co (TSE:7079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127

Website

https://www.wdbcoco.com

WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines